Regeneron (NASDAQ: REGN) reported Q2 EPS of $12.89, $4.39 better than the analyst estimate of $8.50. Revenue for the quarter came in at $3.68 billion versus the consensus estimate of $3.29 billion.

For earnings history and earnings-related data on Regeneron (REGN) click here.